William J.Evans, PhD.
University of California, Berkeley

Recipient of the ICFSR 2022 Lifetime Achievement Award for his pivotal contributions to the identification of sarcopenia as a clinical syndrome and his career-long work in the fields of nutrition, exercise physiology and healthy aging.


Bess Dawson-Hughes, MD.

Bone and muscle interactions

Bess Dawson-Hughes, M.D.
Tufts University
Boston , MA (USA)

Bess Dawson-Hughes graduated from Tufts University School of Medicine and completed her house training at Tufts and an endocrine fellowship at Harvard. She leads research at in bone metabolism at the USDA Human Nutrition Research Center on Aging and is a Professor of Medicine at Tufts. She is the General Secretariat of the International Osteoporosis Foundation and is a past president of the National Osteoporosis Foundation. She was a founding Director of the Center for the Advancement of Science in Space. This board directs research and technology development on the International Space Station National Laboratory.

Her research is directed at determining ways in which calcium, vitamin D, protein and the acid-base balance of the diet influence age-related bone and muscle loss. She has published over 400 peer-reviewed journal articles, book chapters, and reviews. She has received many awards for her research and scientific leadership including the IOF President’s Metal and the IOF Award for Scientific Achievement. She was cited in the Thomson Reuters report on ‘Highly Cited Researchers’, which included scientists who had published the greatest number of highly cited papers (in the top 1% of citations) in the field of clinical research in 2002 through 2013.


William J. Evans, PhD

Defining Sarcopenia: The Good, The Bad, and The Ugly

William J.Evans, PhD.
University of California, Berkeley

William J. Evans, PhD is an Adjunct Professor of Medicine at the Duke University Medical Center and Human Nutrition in the Department of Nutritional Sciences at the University of California, Berkeley. He has served as laboratory director at the Reynolds Institute on Aging at the University of Arkansas for Medical Sciences, the Noll Physiological Research Center at Penn State and as the Chief of the Human Physiology Laboratory at the Human Nutrition Research Center on Aging at Tufts University. He is a Fellow of the American College of Sports Medicine, The American College of Nutrition, and an honorary member of the Academy of Nutrition and Dietetics.
With an H-index of 117, he is the author or co-author of more than 300 publications in scientific journals and was the first to describe sarcopenia. Along with Irwin Rosenberg, he is the author of the bestseller, Biomarkers: The Ten Determinants of Aging You Can Control (Simon & Schuster) and authored AstroFit (Simon & Schuster, 2002). His studies have demonstrated the ability of older men and women to improve strength, fitness, and health through exercise, even into the 10th decade of life. His research has examined the effects of bed rest on body composition, muscle metabolism and functional capacity in old men and women, biomarkers for changes in muscle mass and function, and the etiology of late life dysfunction.
He is the co-inventor of a non-invasive and accurate measurement of muscle mass which is strongly related to health outcomes in older people. His work has been featured in the PBS series, NOVA, Good Morning America, 20/20, CBS evening news, CNN, and the New York Times. He was invited to testify before the US senate select committee on Aging on strategies to preserve Medicare through prevention. He is a founding member of the Society for Sarcopenia, Cachexia, and Wasting Disorders.

James L. Kirkland, M.D., PH.D.

Geroscience Clinical Trials: Strategies for Translating Agents Targeting Fundamental Aging Mechanisms into Clinical Interventions

James L. Kirkland, M.D., PH.D.
Mayo Clinic
Rochester, MI (USA)

The major research focus of James L. Kirkland, M.D., Ph.D., is the impact of cellular aging (senescence) on age-related dysfunction and chronic diseases, especially developing methods for removing these cells and alleviating their effects. Senescent cells accumulate with aging and in such diseases as dementias, atherosclerosis, cancers, diabetes and arthritis, even in younger people.
The goal of Dr. Kirkland's current work is to develop methods to remove these cells to delay, prevent, alleviate or partially reverse age-related chronic diseases as a group and extend health span, the period of life free of disability, pain, dependence and chronic disease.

Focus areas Cellular senescence.
Senolytic drugs.
Diabetes, other chronic diseases and cellular senescence
Significance to patient care
Dr. Kirkland's work is important in developing methods to enhance health span and delay onset of chronic age-related diseases as a group, rather than one at a time. These conditions, including diabetes, dementias, atherosclerosis, cancers and arthritis, among others, account for the bulk of morbidity, mortality and health care costs throughout most of the world.


Roger A. Fielding, Ph.D.

Disordered nutrition and frailty: the intersection of appetite decline and altered energy requirements with advancing age

Roger A. Fielding., PH.D.
Tufts University
Boston , MA (USA)

Roger A. Fielding, Ph.D. is Associate Director of the Jean Mayer USDA Human Nutrition Research Center on Aging at Tufts University and serves as Director and Senior Scientist of the Nutrition, Exercise Physiology, and Sarcopenia (NEPS) Laboratory. He is also Professor of Nutrition at the Friedman School of Nutrition Science and Policy, Professor of Medicine at Tufts University School of Medicine and the Associate Director of the Boston Claude D. Pepper Older Americans Independence Center. Dr. Fielding is an internationally known researcher who studies the underlying mechanisms contributing to the age-associated decline in skeletal muscle mass, the resultant impact on function, and the potential role of exercise, nutrition, physical activity and other therapies on attenuating this process. He has published over 200 peer-reviewed paper (H-index 69).
Dr. Fielding has a strong record of extramural funding including support from the NIH, USDA, foundations and industry. He is an associate editor of the Journals of Gerontology Medical Sciences, and Calcified Tissues International and Musculoskeletal Research. He has also served as a reviewer on numerous NIH study sections and was elected to the NIH/CSR College of Reviewers. In 2015, he received the Olof Johnell Science Award from the International Osteoporosis Foundation.


Preliminary Program

Coming Soon

Call for abstracts

Symposium / Oral Communication / Poster: deadline February 1, 2022